American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, et al. (2004) Consensus development conference on antipsychotic drugs and obesity and diabetes. J Clin Psychiatry65: 267–272.
2.
ArrangJMGarbargMQuachTT. (1985) Actions of betahistine at histamine receptors in the brain. Eur J Pharmacol111: 73–84.
3.
DengCLianJPaiN. (2012) Reducing olanzapine-induced weight gain side effect by using betahistine: A study in the rat model. J Psychopharmacol26: 1271–1279.
4.
FernøJVarelaLSkredeS. (2011) Olanzapine-induced hyperphagia and weight gain associate with orexigenic hypothalamic neuropeptide signaling without concomitant AMPK phosphorylation. PLoS One6: e20571.
5.
GbahouFDavenasEMorissetS. (2010) Effects of betahistine at histamine H3 receptors: Mixed inverse agonism/agonism in vitro and partial inverse agonism in vivo. J Pharmacol Exp Ther334: 945–954.
6.
GoudieAJHalfordJCDoveyTM. (2003) H(1)-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. Neuropsychopharmacology28: 2209; author reply 2210–2211.
7.
KimSFHuangASSnowmanAM. (2007) From the Cover: Antipsychotic drug-induced weight gain mediated by histamine H1 receptor-linked activation of hypothalamic AMP-kinase. Proc Natl Acad Sci U S A104: 3456–3459.
8.
KirkSLGlazebrookJGraysonB. (2009) Olanzapine-induced weight gain in the rat: Role of 5-HT2C and histamine H1 receptors. Psychopharmacology (Berl)207: 119–125.
9.
KroezeWKHufeisenSJPopadakBA. (2003) H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. Neuropsychopharmacology28: 519–526.
10.
Matsui-SakataAOhtaniHSawadaY (2005) Receptor occupancy-based analysis of the contributions of various receptors to antipsychotics-induced weight gain and diabetes mellitus. Drug Metab Pharmacokinet20: 368–378.
11.
PillotCHeronACochoisV. (2002) A detailed mapping of the histamine H(3) receptor and its gene transcripts in rat brain. Neuroscience114: 173–193.
12.
ReynoldsGPKirkSL (2010) Metabolic side effects of antipsychotic drug treatment — pharmacological mechanisms. Pharmacol Ther125: 169–179.
